When workplacedrug testing comes up, the conversation usually revolves around alcohol and illegal substances.

But what happens when an employee tests positive after taking medication prescribedby a healthcare professional? It is a scenario that employers and employees need to understand, particularly in safety-critical industries such as mining, construction, manufacturing and transport.

Medication that helps someone manage pain, anxiety or another health condition can also affect their alertness, concentration and reaction time. In some cases, it can trigger a positive workplace drugscreening result. Understanding what that result means is essential to protecting workplace safety while treating employees fairly.

Prescription medication can trigger positive results

The most important thing to know is that workplace drug tests typically screen for groups of substances rather than identifying a specific drug. The substances included depend on the testing panelselected by the employer, but commonly used panels may screen for cannabis, cocaine, opiates, amphetamines, methamphetamine and benzodiazepines.

Several of these substance categories overlap with commonly prescribed medication. Opioid-based painkillers, some ADHD medications and benzodiazepines such as diazepam (Valium) may produce positivescreening results, while others can also interfere with screening tests, depending on the test used.

A positive result does not automatically mean an employee has taken an illegal drug. Nor does a prescription automatically mean a medication is safe for every working environment. For example, a medicinethat causes drowsiness may be unsuitable immediately before operating a forklift, driving a heavy vehicle or working with high-voltage electrical equipment.

The risk depends on the medication, dosage, timing, individual response and duties involved. As such, employees should tell their prescribing healthcare professional what their job entails and askwhether the medication could affect their ability to work safely. Prescriptions should also have a clearly defined treatment period and be reviewed where appropriate, particularly when medication carries a risk of dependence or tolerance.

Screening is not the final answer

Before acting on a positive screening result, employers need to establish which substance has been detected. Confirmatory laboratory testing can identify specific substances and distinguish betweencompounds that may produce similar initial results.

For example, some ADHD medications can trigger a positive screening result for amphetamines. Further testing can help establish which substance is present, while prescription records and supportingmedical documentation can provide important context.

An over-the-counter testing kit may provide an initial result, but the result alone does not explain its significance or how an employer should respond. Working with a qualified drug-testing serviceprovider can help employers understand the limitations of screening, arrange confirmatory testing where appropriate and follow a clear process for managing positive results. Professional guidance can also help establish protocols that protect medical privacy,support fair treatment and manage workplace safety risks.

Employers should follow their workplace alcohol and substance policywhen investigating positive results, arranging confirmatory testing and protecting employees’ medical privacy. A clear, consistent process, supported by a reputable drug-testing service provider, helps ensure that each case is handled fairly and that a preliminaryresult is not treated as automatic proof of illicit drug use or misconduct.

A positive result does not automatically equate to impairment

It’s also important to keep in mind that drug testing and impairment assessment are not the same thing. Unlike a breathalyzerresult, which can be interpreted against established alcohol limits, a drug test does not provide a straightforward measure of how impaired someone is at that moment. Detection windows also vary. Urine tests can identify some substances after their impairingeffects have passed, while saliva tests generally focus on more recent use. However, a positive saliva result does not conclusively establish impairment either.

Employers should therefore consider the test result alongside relevant observations of the the employee’s behaviour and the surrounding circumstances. Signs such as unusual drowsiness, impaired coordinationor difficulty concentrating may warrant further assessment, although no single observation is proof of drug use or impairment. The priority is always to prevent someone who may be unfit for duty from performing safety-critical work while ensuring decisionsare evidence-based and consistent with workplace procedures.

Education creates safer, fairer workplaces

Knowing what a drug test detects is only part of the picture. Employees also need to understand how prescription medication could affect their test results and their ability to work safely. Employerscan help by making this information accessible through awareness sessions, practical guidance and clear workplace policies. A reputable drug-testing provider should do more than supply testing kits. By building awareness sessions and practical guidance intoits service, the provider can help employees understand how medication may affect screening results and workplace safety. This education should be grounded in clear workplace policies, so employees understand both the risks and the procedures they are expectedto follow.

These policies should also clearly state when employees must disclose medication use, how positive screening results will be managed, when confirmatory testing is necessary, and how medical informationwill be safeguarded. Regular reviews help keep procedures aligned with current requirements and best practice.

Employees should discuss potential side effects with their healthcare professional and explain the demands of their job. Employers need to follow a fair, consistent process that takes both safety andlegitimate medical treatment into account. The goal is to identify and manage genuine risks, not to mistake a prescription or a positive screening result for proof of wrongdoing.